US 7718670
Quinuclidine amide derivatives
granted A61PA61P1/00A61P11/00
Quick answer
US patent 7718670 (Quinuclidine amide derivatives) held by Laboratories Almirall, S.A. expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Laboratories Almirall, S.A.
- Grant date
- Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P1/00, A61P11/00, A61P13/00, A61P25/02